The DOI matches its Crossref record; 119 of the 119 references it cites were found in a registry or an index.
Molecular Imaging of Coronary Atherosclerosis and Myocardial Infarction: Considerations for the Bench and Perspectives for the Clinic
Open accessAbstract
Motivated by the promise to transform preclinical research and clinical care, cardiovascular molecular imaging has made advances toward targeting coronary atherosclerosis and heart failure. Here, we discuss recent progress in the field, highlight how molecular imaging may facilitate preventive patient care, and review specific challenges associated with coronary and heart failure imaging. Practical considerations stress the potential of fluorescence imaging for basic research and discuss hybrid protocols such as FMT-CT and PET-MRI.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“For molecular imaging purposes both techniques were initially considered to lack sufficient sensitivity for the detection of exogenously administered molecular imaging agents, but with the rise of new and potent nanoparticulate agents MRI and CT are increasingly being explored for this purpose119.”
From Perspectives and opportunities for nanomedicine in the management of atherosclerosis (2011) · cites this paper as [119]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Atherosclerosis--an inflammatory disease
Ross, R. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901143400207 · Cited by 21,725
Inflammation in atherosclerosis
Libby, P. (2002) · Nature · doi:10.1038/nature01323 · Cited by 8,315
Quantum Dots for Live Cells, in Vivo Imaging, and Diagnostics
Michalet, X., Pinaud, F. F., Bentolila, L. A., Tsay, J. M., Doose, S., Li, J. J., Sundaresan, G., Wu, A. M., Gambhir, S. S., & Weiss, S. (2005) · Science · doi:10.1126/science.1104274 · Cited by 7,794
Heart Disease and Stroke Statistics—2010 Update: A Report From the American Heart Association
WRITING GROUP MEMBERS, Lloyd-Jones, D., Adams, R. J., Brown, T. M., Carnethon, M., Dai, S., De Simone, G., Ferguson, T. B., Ford, E., Furie, K., et al. (2010) · Circulation · doi:10.1161/circulationaha.109.192667 · Cited by 5,700
Optimal Medical Therapy with or without PCI for Stable Coronary Disease
Boden, W. E., O'Rourke, R. A., Teo, K. K., Hartigan, P. M., Maron, D. J., Kostuk, W. J., Knudtson, M., Dada, M., Casperson, P., Harris, C. L., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa070829 · Cited by 4,699
Inflammation in Atherosclerosis
Libby, P. (2012) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.108.179705 · Cited by 3,796
Imaging in the era of molecular oncology
Weissleder, R., & Pittet, M. J. (2008) · Nature · doi:10.1038/nature06917 · Cited by 2,420
Pathology of the Vulnerable Plaque
Virmani, R., BURKE, A. P., Farb, A. A., & Kolodgie, F. D. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.10.065 · Cited by 2,358
Nahrendorf, M., Swirski, F. K., Aikawa, E., Stangenberg, L., Wurdinger, T., Figueiredo, J.-L., Libby, P., Weissleder, R., & Pittet, M. J. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20070885 · Cited by 2,300
Self-citationIdentification of splenic reservoir monocytes and their deployment to inflammatory sites
Swirski, F. K., Nahrendorf, M., Etzrodt, M., Wildgruber, M., Cortez-Retamozo, V., Panizzi, P., Figueiredo, J.-L., Kohler, R. H., Chudnovskiy, A., Waterman, P., et al. (2009) · Science · doi:10.1126/science.1175202 · Cited by 2,221
Self-citation
Research works printed but not linked: 1
- 10.1172/JCI200420352 · DOI
Cited by
Sorted by citations
Perspectives and opportunities for nanomedicine in the management of atherosclerosis
Lobatto, M. E., Fuster, V., Fayad, Z. A., & Mulder, W. J. M. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3578 · Cited by 423
PET imaging of inflammation in atherosclerosis
Tarkin, J. M., Joshi, F. R., & Rudd, J. H. F. (2014) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2014.80 · Cited by 388
PET/MRI of Inflammation in Myocardial Infarction
Lee, W. W., Marinelli, B. S., van der Laan, A. M., Sena, B. F., Gorbatov, R., Leuschner, F., Dutta, P., Iwamoto, Y., Ueno, T., Begieneman, M. P. V., et al. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.08.066 · Cited by 349
Self-citationCardiac macrophages and their role in ischaemic heart disease
Frantz, S., & Nahrendorf, M. (2014) · Cardiovascular Research · doi:10.1093/cvr/cvu025 · Cited by 327
Self-citationSynthesis, Functionalization, and Design of Magnetic Nanoparticles for Theranostic Applications
Mosayebi, J., Kiyasatfar, M., & Laurent, S. (2017) · Advanced Healthcare Materials · doi:10.1002/adhm.201700306 · Cited by 250
Metadata
- Authors
- Leuschner, F., & Nahrendorf, M.
- Affiliations
- Harvard University (US)
- Venue
- Circulation Research
- Published
- 2011-03-04
- Volume
- 108
- Issue
- 5
- Pages
- 593-606
- ISSN
- 0009-7330 (ISSN-L)
- 1524-4571
- PMC
- PMC3397211
- OpenAlex
- W2061136178
- Cited by
- 110
- References
- 119
- Citations by year
- 2026: 2 · 2025: 3 · 2024: 5 · 2023: 1 · 2022: 1 · 2021: 1 · 2020: 4 · 2019: 5 · 2018: 4 · 2017: 6 · 2016: 9 · 2015: 12 · 2014: 17 · 2013: 16 · 2012: 21
- FWCI
- 2.95
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Circulation Research (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Circulation Research
- Funders
- American Heart Association
- Deutsche Herzstiftung
- National Heart, Lung, and Blood Institute (HHSN268201000044C, R01HL095629, R01HL096576)
- National Institute of Biomedical Imaging and Bioengineering (R01EB006432)
- Topics
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Cardiac Imaging and Diagnostics
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Medical Imaging Techniques and Applications
- Life Sciences › Immunology and Microbiology › Immunology › Atherosclerosis and Cardiovascular Diseases
- Keywords
- coronary artery disease, myocardial infarction, fluorescence imaging, PET/MR imaging, atherosclerosis imaging, preventive cardiology
- MeSH terms
- Coronary Artery Disease, Humans, Magnetic Resonance Imaging, Myocardial Infarction, Tomography, X-Ray Computed, Positron-Emission Tomography, Molecular Imaging
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
